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ABSTRACT 
The f luor imetr ic  quantitation of nanogram amounts of es t r io l  
extracted f rom plasma is somet imes impaired by impuri t ies  which 
in ter fere  with f luorescence.  Instant th in- layer  chromatography on 
sil ica gel impregnated glass fiber sheets (ITLC-SG) removes  such 
impuri t ies  originating from extracts  as well as from solvents used 
in the course of analysis .  This convenient, rapid and effective 
chromatographic procedure does not introduce interfer ing substances 
by itself.  With the uti l ization of ITLC, plasma es t r io l  assays  proved 
to be precise ,  specific and accurate.  
The f i r s t  relat ively simple and generally applicable method 
for ser ia l  clinical determinat ions of plasma es t r io l  (3) concentrations 
during the second half of human pregnancy was published by Nachtigall 
et al. (4). With this method, f luor imetry has proven to be a pract ica l  
way of quantitating nanogram amounts of es t r iol  derived from plasma 
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extracts .  In attempting to adapt our method of measur ing ur inary  
es t r io l  in pregnancy (5) to the determination of plasma es t r io l  in the 
second half of gestation, unsat isfactory precis ion and accuracy were 
encountered although methylation, additional solvent parti t ion and 
chromatography on alumina were used to remove impurit ies which 
not infrequently in ter fere  with fluoresence. Such impurit ies may 
ar ise  from plasma or other biological fluids as well as from solvents 
used during the extraction and purification procedures.  A purifioation 
step appeared necessary  which would effectively remove these impu- 
r i t ies  and not introduce interfer ing substances inherent in many 
chromatographic procedures.  
This report  describes the use of instant th in- layer  chromato-  
graphy (ITLC) on sil ica gel impregnated glass fiber sheets to improve 
specificity,  accuracy and precision in the measurement  of plasma 
estr iol .  
EXPERIMENTAL 
Materials .  Solvents and reagents were of analytical  grade 
unless otherwise stated. All solvents except diethyl ether  (USP, 
Mallinckrodt Chemical Works) were disti l led prior  to use. Benzene 
was shaken for 3 hours with concentrated sulfuric acid, washed 
successively with distil led and demineral ized water,  a sa tura ted  
sodium carbonate solution and again with water and was finally 
dist i l led over sodium hydroxide pellets. P-nitrophenol (lVIP 113-114 ° C) 
was purchased from Matheson, Coleman & Bell, East Rutherford, N . J . ,  
hydroq,,~none (extra pure, Merck) and sulfuric acid (ultra pure, Merck) 
from Brinkmann Instruments,  Westbury, N.Y.,  and si l ica gel irnpreg- 
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nated glass fiber sheets (ITLC-SG) from Gelman inst rument  Company 
Ann Arbor,  Michigan. Estr iol-6,  7-3H was purchased from A m e r s h a m /  
Searle, DesPlaines,  Ill . ,  and uridine-5 '-diphosphoglucuronic acid from 
Sigma Chemical Company, St. Louis, Mo. All non-labeled steroids 
were purchased from Steraloids, Pawling, N.Y. 
Apparatus. The radioactive mate r ia l  was measured  in a 
Packard  Model 3320 liquid scintil lation spectrometer .  F luor imet ry  
was car r ied  out in an Aminco-Bowraan spectrof luor imeter ,  used 
without f i l ters .  
Prepara t ion  of 3H-estr iol-16-ghicosiduronate.  Estr iol-6,  7_3H 
with a specific activity (S. A. ) of 8 pCi/pg was purified by paper par t i -  
tion chromatography (benzene:methanol:water, 2:1:1). Its radiochemical  
purity was tes ted by crystal l iz ing an aliquot to constant S.A. Radio- 
chemical ly pure es t r iol -6 ,  7-3H was incubated with an homogenate of 
human liver (autopsy mater ia l )  and uridine-5'-diphosphoghicuronic 
acid according to the method of Slaunwhite et al. (6).  The result ing 
3H-estr iol-16-glucosiduronate  was extracted from the incubation 
mixture,  purified by countercurrent  distribution and gel f i l t rat ion on 
Sephadex G-25 and examined for radiochemical  homogeneity as previously 
described (5). 
Preparat ion of non-labeled estr iol-16-glucosiduronate.  Es t r io l -  
16-glucosiduronate (E3-16G1) was prepared s imilar ly  by incubating 100 
mg of crystal l ine es t r io l  (E3) with 1 g-m of uridine-5 '-diphosphoglucuronic 
acid in 200 ml of 0.1 M phosphate buffer, pH = 7.4, containing a homogenate 
of 20 gin of human liver. The E3-16G1 obtained from the incubation 
mixture was subjected to three 24- t ransfer  countercurrent  distributions 
in ethyl acetate:n-butanol:0.2 N NH4OH (1:1:2), in ethyl acetate:  0.1 
N HC1 (1:1) and in n-butanol:water (1:1) with partit ion coefficients of 
1.0, 1.4 and 1.2, respectively.  The mater ia l  obtained was recrys ta l l ized  
from acidified n-butanol. It was dissolved and stored in 80% ethanol 
following neutralization with NH4OH. The yield was 27.2%. It has been 
proven that the es t r io l  conjugate obtained under the above incubation is 
indeed E3-16G1 (7). 
Hydrolysis and extraction procedure.  The method used for plasma 
es t r io l  determinations was essent ial ly that of Nachtigall et al. (4) as 
modified by Levitz and Basset t  (8). One ml of plasma (EDTA is used 
as the anticoagulant) was added into a heavy-wall centrifuge tube of 35 
ml capacity which may be closed with a teflon-lined screw cap. About 
20, 000 DPM of 3H-E3-16G1 was added in 50 pl of 80% ethanol. Two 
ml of dist i l led water  were added together with 0. 60 ml of concentrated 
hydrochloric acid. The tube was closed and kept in boiling water for 
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30 minutes .  The hyd ro ly sa t e  was cooled,  1 ml  of w a t e r  added and the 
m i x t u r e  e x t r a c t e d  twice  w i t h l 0  ml of d ie thyl  e the r ,  us ing a Vor t ex  J r .  
m i x e r  fo r  ex t r ac t ion .  Cent r i fuga t ion  was then p e r f o r m e d  to e f f ec t  r ap id  
s e p a r a t i o n  of the e t h e r  f r o m  the w a t e r  phase .  The e the r  phases  w e r e  
combined  in ano the r  cen t r i fuge  tube,  washed  with 3 m l  of a sodium 
b i c a r b o n a t e  bu f f e r  p r e p a r e d  f r o m  150 m l  of 5 N sodium hydrox ide  and 
1000 ml  8% (w/v) sodium b i ca rbona t e  (9) and f inal ly  washed  twice with 
2 ml  of d i s t i l l ed  wate r .  The e t h e r  phase  was ev ap o ra t ed  and i ts  r e s i d u e  
d i s so lved  in 0. 08 ml  of e thanol  and 4 m l  of d i s t i l l ed  wate r .  This  was 
e x t r a c t e d  with 4 ml  of a b e n z e n e : n - h e x a n e  m ix tu r e  (1:1). The o rgan ic  
phase  was d i s ca rded .  The aqueous phase  was e x t r a c t e d  twice  with 4 ml  
of e t he r ,  which was t r a n s f e r r e d  into a con ica l  t e s t  tube for  evapo ra t i on  
in a w a r m  w a t e r  bath. 
Instant  t h i n - l a y e r  c h r o m a t o g r a p h y .  The res idue  was d i s so lv ed  
in a few drops  of me thano l  and spot ted  on ITLC-SG shee t s  applying 5 
s a mp le s  pe r  shee t  (20 x 20 cm) ad jacent  to 3 #g of authent ic  E 3. The 
ITLC-SG shee t s  w e r e  suspended  in an unl ined t h i n - l a y e r  c h r o m a t o g r a p h y  
j a r  and deve loped  with c h l o r o f o r m  containing 1% ethanol  (v:v). The spot  
of authent ic  E 3 was v i sua l i zed  by the Fol in  r e a c t i o n  (10) and its Rf  u t i l i zed  
to cut  out 3 cm wide zones  of the shee t  containing the E 3. Th ese  zones  
w e r e  e lu ted  with 2 .5  ml  of methanol .  
Quanti tat ion.  In o r d e r  to c o r r e c t  for  p r o c e d u r a l  loss ,  0 .5  m l  
of the e lua te  was taken fo r  l iquid sc in t i l la t ion  counting,  while 1 .5  m l  was 
u se d  fo r  f l u o r i m e t r y .  This  was added to g l a s s - s t o p p e r e d  cen t r i fuge  tubes 
which conta ined  1 ml  of 2% (w:v) hydroquinone in ethanol .  The tubes w e re  
e v a p o r a t e d  u n d e r  n i t rogen  which had been  p a s s e d  th rough  conc.  su l fu r i c  
ac id  and soda l ime.  S ix ty- f ive  p e r  cent  u l t r a - p u r e  su l fu r i c  acid was u sed  
to deve lop  the Kobe r  ch romogens  by boil ing the s t o p p e red  tubes  fo r  40 
minu te s .  Fol lowing the addit ion of 1 .5  ml  of g l a s s - d i s t i l l e d  wa te r ,  the 
f l u o r e s c e n t  m a t e r i a l  was e x t r a c t e d  into c h l o r o f o r m  containing 1% e thanol  
(v:v) and 2% p -n i t ropheno l  (w:v) accord ing  to Mahesh ' s  modi f i ca t ion  (11) 
of  I t t r i c h ' s  p r o c e d u r e  (12). Under  these  condit ions us ing  tubes  c l eaned  
with su l fu r i c  ac id  and assay ing  not  m o r e  than 12 tubes  at  a t ime  (13), 
c a l i b r a t i on  c u r v e s  we re  wel l  r ep roduc ib le .  A l i n e a r  r e g r e s s i o n  l ine 
with a coe f f i c i en t  of c o r r e l a t i o n  of 0.99 was obta ined in 4 s u c c e s s i v e  
ca l i b r a t i ons  with amounts  ranging f rom  5-100 ng of e s t r i o l .  
RESULTS 
Separa t ion  of e s t r o g e n s  on ITLC. The c h r o m a t o g r a p h i c  b e h a v i o r  
of 9 e s t r o g e n s  on ITLC-SG has been  s tudied in s e v e r a l  so lvent  s y s t e m s .  
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Since c h l o r o f o r m  was  the so lven t  u s e d  to e x t r a c t  the f l u o r e s c e n t  m a t e r i a l  
f r o m  the s u l f u r i c  a c i d / w a t e r  m i x t u r e  fo r  f l u o r i m e t r y ,  c h l o r o f o r m  w a s  
p r e f e r r e d  fo r  the d e v e l o p m e n t  of the I T L C - S G  s h e e t  in th is  a s s a y ,  s ince  
i ts  i m p u r i t i e s  would be l e a s t  l i ke ly  to i n t e r f e r e  wi th  f l u o r e s c e n c e .  Solvent  
s y s t e m  No. 2 conta in ing  1% ethanol  in c h l o r o f o r m  was  u sed  in p l a s m a  
e s t r i o l  a s s a y .  
Tab l e  1. 
R F v a l u e s  fo r  9 e s t r o g e n s  on I T L C - S G  in the fol lowing so lven t  s y s t e m s :  
1) 2% e thanol  in c h l o r o f o r m ;  2) 1% e thanol  in c h l o r o f o r m  3) c h l o r o f o r m ;  
4) cyc lohexane  : c h l o r o f o r m  (3:7) ; 5) c y c l o h e x a n e : c h l o r o f o r m  (2:3); 6) 
e t h e r : b e n z e n e  (1:9) and 7) e thyl  a c e t a t e : c y c l o h e x a n e  (1:9). E a c h  f igure  
r e p r e s e n t s  the m e a n  R F of 3 c h r o m a t o g r a p h i c  runs .  
Solvent  S y s t e m s  
Compound 1 2 3 4 5 6 7 




1 6 a - H O - E  1 
1 6 - o x o - E  2 
1 6 ~ - H O - E  1 
1 7 - e p i - E  3 
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P r e c i s i o n .  The  p r e c i s i o n  of the p r o c e d u r e  was  e s t i m a t e d  by 
having  one t echn ic i an  c a r r y  out 14 r e p l i c a t e  a s s a y s  on two c o n s e c u t i v e  
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days  on a pool  of p l a s m a  c o l l e c t e d  f r o m  women  in the second  ha l f  of 
ge s t a t i on  and by  ca l cu l a t i ng  the s t a n d a r d  dev ia t ion  (S. D. ) of the r e s u l t s  
+ 
f r o m  t h e i r  mean .  The m e a n  c o n c e n t r a t i o n  and i ts  S .D.  w e r e  20 .4  - 1 .2  
pg /100  m l  of p l a s m a ,  ind ica t ing  a coef f ic ien t  of v a r i a t i o n  of + 5.7%. 
Snedeco r  (14) s u g g e s t e d  a me thod  of obtaining an e s t i m a t e  of 
p r e c i s i o n  in which the S .D.  is ca l cu la t ed  f r o m  the d i f f e r e n c e  be tween  
the two r e s u l t s  of dup l ica te  d e t e r m i n a t i o n s  in a s e r i e s  of a s s a y s .  F o r t y -  
s even  dupl ica te  d e t e r m i n a t i o n s  w e r e  c a r r i e d  out and the S. D. was  c a l c u l a t e d  
as  s u g g e s t e d  by  Snedecor  (14) e x c e p t  tha t  the d i f f e r ence  be tween  the 
r e s u l t s  of e a c h  p a i r  of a s s a y s  was  e x p r e s s e d  in p e r  cent  of the m e a n  
of the two r e s u l t s .  The coe f f i c i en t  of v a r i a t i o n  in this s e r i e s  of 
+ 
dupl ica te  a s s a y s  was  found to be  - 2.9%. 
A c c u r a c y .  The a c c u r a c y  was  d e t e r m i n e d  by m e a s u r i n g  the 
r e c o v e r y  of e s t r i o l  added to p l a s m a  in the f o r m  of E3-16G1. T w e n t y -  
four  s a m p l e s  w e r e  ana lyzed  a f t e r  amoun t s  of 250, 333 and 500 ng of 
e s t r i o l  w e r e  added to 1 ml  a l iquots  of pooled ma le  p l a s m a .  The r e s u l t s  
a r e  ind ica ted  in F i g u r e  1. Using the i n t e rna l  s t anda rd  to c o r r e c t  for  
p r o c e d u r a l  l o s s ,  v i r t u a l l y  a l l  of the e s t r i o l  added as  the 1 6 - g l u c o s i d u r o n a t e  
was  accoun ted  fo r .  
Sens i t iv i ty .  When pooled m a l e  p l a s m a  was ana lyzed  in 7 r e p l i c a t e  
a s s a y s ,  a r e a d i n g  was  obtained,  which a f t e r  c o r r e c t i o n  for  p r o c e d u r a l  
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E STRIOL RECOVERED 
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Fig. 1. Recovery  of es t r io l  added to p lasma in the 
form of es t r io l -16-g lucos iduronate .  
loss,  amounted to an equivalent of 1.1 + 0.3 pg of e s t r io l  per  100 ml 
of plasma.  When 8 water  blanks were assayed  in the same manner ,  
comparable  resu l t s  were  obtained. Thus the proposed method is not 
suitable for p lasma es t r io l  assays  p r i o r  to the 20th week of gestation, 
when es t r io l  reaches  a plasma concentrat ion of about 4 pg/100 ml. 
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Plasma e s t r i o l  levels  in pregnancy.  P l a sma  es t r io l  levels  were  
de termined  once or  s eve ra l  t imes  at  biweekly intervals  in 40 healthy 
pregnant  women with uncomplicated pregnancies  (Fig. 2). Since plasma 
levels  of e s t r i o l  a re  subject  to diurnal  changes (15), all specimens were  
drawn between 8 and 11 a . m .  The measu remen t s  agreed well with those 
repor ted  by Nachtigall  et  al. (4) reaching levels in excess  of 40 pg/100 ml 
E S T R I O L  
5 0 -  .ug I 1 0 0  m! 
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3 0  
20' 
1 0  
." • 
O'  I 
2 0  
I ' ' ' 1 ,  
24 2 8  
• Ib • 
| • 
• ~ e e  
' ' I ' ' J ! T , , • 
32 3 6  4 0  
WEEKS OF GESTATION 
Fig. 2. P l a sma  es t r io l  concentrat ions from 40 normal  
women during the second half of gestation. 
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at  te rm.  Although the normal  increase  in ur inary  es t r io l  excret ion was 
not always paral led by a concomitant r ise  in p lasma concentrations,  
p lasma es t r io l  levels general ly appeared to r ise  most  rapidly during 
the las t  5 or 6 weeks of gestation as did the ur inary  es t r io l  excretion. 
DISCUSSION 
The steady increase  in es t r io l  biosynthesis,  p lasma concentration 
and ur inary  excretion during human pregnancy is uti l ized for evaluating 
fetal well-being (16). The bulk of materna l  p lasma and ur inary  es t r io l  
is produced by fetus and placenta (17) and readily t r ans fe r red  to the 
materna l  circulation (7, 18, 19). Estr iol  metabolism in the mother  
consists  mainly of conjugation while the es t r io l  moiety remains  largely 
unchanged (20-22). The determination of ur inary  es t r io l  excretion has 
proven to be a valuable diagnostic adjunct in obstetr ics  but is burdened 
with the inconvenience, delay and frequent inaccuracy in collecting a 
24-hour urine specimen. Much in teres t  has therefore been focused on 
plasma estr iol  assays .  
The f luor imetr ic  quantitation of nanogram amounts of 'es t r iol  has 
the advantages of convenience, relat ive specificity and sufficient sensitivity. 
However, accuracy and precision are  somet imes inadequate due to impu- 
r i t ies  which enhance or, more frequently quench, f luorescence.  Such 
impuri t ies  are  extracted from biologic specimens and not dissociated 
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f rom es t r io l  during purif icat ion p rocedures .  Additional impur i t ies  a re  
often introduced with solvents and reagents .  In an at tempt to adapt our 
method for  u r ina ry  es t r io l  de terminat ion (5) to plasma es t r io l  assay  we 
used methylat ion,  benzene /wa te r  part i t ion and chromatography on alumina 
columus to fu r the r  purify our p lasma ext rac ts .  P rec i s ion  and accuracy ,  
however,  were  sti l l  inadequate and it was found that the solvents and 
reagents  involved in this step contr ibuted impuri t ies  which quenched 
f luorescence .  
The use of s i l ica gel impregnated  glass f iber  sheets  for  the 
separat ion of phenolic s tero id  sulfate has been descr ibed by Payne 
and Mason (23). These ITLC sheets,  when developed in ch loroform 
and eluted with methanol,  did not contribute enhancing or quenching 
impuri t ies  to the f luo r ime t r i c  quantitation of estr iol .  
The ITLC used in this assay  separa tes  es t r io l  f rom es t rone,  
es t radio l  and other  es t rogens .  Thus the part i t ion between water  
containing 2% ethanol and benzene:n-hexane (1:1) may seem superfluous 
since it was designed by Brown (9) to separa te  es t r io l  f rom es t rone  
and es t radiol .  This part i t ion,  c a r r i e d  out twice in the method of 
Nachtigall e t  al. (4), has been re ta ined in the form of one par t i t ion 
in o rde r  to remove  lipids p r i o r  to ITLC. In our exper ience,  lipids 
i n t e r f e red  with the migrat ion of es t rogens  on ITLC-SG which provides  
good re  s oluti on but has l imited capacity. 
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The precis ion of the method is acceptable as is its accuracy,  the 
la t ter  being assessed  in regard  to the recovery of E3-16G1. Although 
Erte l  et al. (24) presented evidence that there was no difference in the 
measurement  of plasma es t r io l  whether t r i t ia ted E3, E3-16G1 or E3-3S 
was used as an internal  standard, our method uti l izes 3H-est r io l -16-  
glucosiduronate as suggested by Levitz and Basset t  (8). More recently,  
the p lasma es t r io l  method described in this paper has been used in our 
laboratory for the measurement  of es t r io l  levels in amniotic fluid. 
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The following t r iv ia l  names and abbreviations a re  used in this paper:  
estrone (E 1) = 3-hydroxyest ra-1 ,  3, 5 (10)-trien-17-one; 2-methoxy- 
estrone (2MeO-E 1) = 2-methoxy-3-hydroxyest ra-1 ,  3, 5 (10)-trien-17- 
one; 17~-estradiol  (E2)= es t ra-1 ,  3,5(10)-triene-3,  17~-diol; 16a- 
hydroxyestrone (16aOH-E1) = 3, 16a-dihydroxyestra-1,  3, 5(10)-trien- 
17-one; 16~-hydroxyestrone (16~OH-E 1) = 3, 16~-dihydroxyestra-1,  3, 5 
(10)-trien-17-one; 16-ketoestradiol-17~ (16-oxoE2) = 3, 17~-dihydroxy- 
es t ra -1 ,  3, 5(10)-trien-16-one; 16-epiestr iol  (16epiE3) = es t ra -1 ,  3, 5(10)- 
646 S T E R O I D S 16:6 
t r iene-3 ,  16~, 17~-triol;  17-epie s t r i o l  (17epiE 3) = es t r a -  1, 3, 5 (10)-triene- 
3, 16a, 17a-triol;  es t r io l  (E3) = es t ra -1 ,  3,5 (10)-triene-3, 16a, 17~-triol; 
es t r io l -16-glucosiduronate  (E3-16G1) = 3, 17~-dihydroxyestra-1,  3, 5(10)- 
t r ien-16~-yl-~-D-glucopyranosiduronate ;  es t r io l -3-su l fa te  (E3-3S) = 16~, 
17~-dihydroxyestra-1,  3, 5 (10)- t r ien-3-yl-sulfate;  es t r io l -3 -su l fa te -16-  
glucosiduronate (E3-SG1) = 17~-hydroxyestra-1,  3, 5(10)- t r ien-3-yl-  
sulfate-16a-yl-~-D-glucopyranosiduronate .  
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